Summary of the TRIIM-S Study by Dr. Gregory Fahy The TRIIM-S (Thymus Regeneration, Immunorestoration, and Insulin Mitigation) study, led by Dr. Gregory Fahy, explores the potential of regenerative therapies to reverse biological aging. Building on the success of the original TRIIM study, which demonstrated the possibility of rejuvenating the thymus gland and improving immune function, TRIIM-S aims to further investigate these effects and expand the understanding of aging reversal. Key Points: Objective: To evaluate the efficacy of a combination of growth hormone, metformin, DHEA, and other agents in reversing biological aging and improving immune function. Methods: Participants undergo treatment and are monitored for changes in biomarkers of aging, immune function, and overall health. Results: The original TRIIM study showed promising results, including thymus regeneration and a reduction in biological age. TRIIM-S aims to replicate and expand these findings. Significance: The TRIIM-S study could pave the way for new anti-aging therapies, potentially extending healthy lifespan and improving quality of life for older adults. HgH, DHEA-s and Metformin were utilized in the study.

Living Younger with Science: TRIIM 2

Metformin

Shopping cart

0
image/svg+xml

No products in the cart.

Continue Shopping
Text Us!